These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 28482407)

  • 41. [Prediction of short-term prognosis of hepatocellular carcinoma after TACE surgery based on MRI texture analysis technology].
    Weng W; Lü XL; Zhang QQ; Zhao XM; Chen CM; Kong CL; Lu CY; Chen MJ; Ji JS
    Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(11):828-832. PubMed ID: 32234153
    [No Abstract]   [Full Text] [Related]  

  • 42. Dual-phase Cone-beam CT-based Navigation Imaging Significantly Enhances Tumor Detectability and Aids Superselective Transarterial Chemoembolization of Liver Cancer.
    Yao X; Yan D; Jiang X; Li X; Zeng H; Liu D; Li H
    Acad Radiol; 2018 Aug; 25(8):1031-1037. PubMed ID: 29398432
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Histogram Analysis of CT Perfusion of Hepatocellular Carcinoma for Predicting Response to Transarterial Radioembolization: Value of Tumor Heterogeneity Assessment.
    Reiner CS; Gordic S; Puippe G; Morsbach F; Wurnig M; Schaefer N; Veit-Haibach P; Pfammatter T; Alkadhi H
    Cardiovasc Intervent Radiol; 2016 Mar; 39(3):400-8. PubMed ID: 26216725
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Warming effect on miriplatin-lipiodol suspension as a chemotherapeutic agent for transarterial chemoembolization for hepatocellular carcinoma: preliminary clinical experience.
    Kora S; Urakawa H; Mitsufuji T; Osame A; Higashihara H; Yoshimitsu K
    Cardiovasc Intervent Radiol; 2013 Aug; 36(4):1023-9. PubMed ID: 23238851
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Radiological response and inflammation scores predict tumour recurrence in patients treated with transarterial chemoembolization before liver transplantation.
    Nicolini D; Agostini A; Montalti R; Mocchegiani F; Mincarelli C; Mandolesi A; Robertson NL; Candelari R; Giovagnoni A; Vivarelli M
    World J Gastroenterol; 2017 May; 23(20):3690-3701. PubMed ID: 28611522
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Optimal methods for measuring eligibility for liver transplant in hepatocellular carcinoma patients undergoing transarterial chemoembolization.
    Kim HD; Shim JH; Kim GA; Shin YM; Yu E; Lee SG; Lee D; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS
    J Hepatol; 2015 May; 62(5):1076-84. PubMed ID: 25529626
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Feasibility of MDCT angiography for determination of tumor-feeding vessels in chemoembolization of hepatocellular carcinoma.
    Kim I; Kim DJ; Kim KA; Yoon SW; Lee JT
    J Comput Assist Tomogr; 2014; 38(5):742-6. PubMed ID: 24834885
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The prognostic value of 18F-FDG PET/CT for hepatocellular carcinoma treated with transarterial chemoembolization (TACE).
    Ma W; Jia J; Wang S; Bai W; Yi J; Bai M; Quan Z; Yin Z; Fan D; Wang J; Han G
    Theranostics; 2014; 4(7):736-44. PubMed ID: 24883123
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center.
    Vogl TJ; Trapp M; Schroeder H; Mack M; Schuster A; Schmitt J; Neuhaus P; Felix R
    Radiology; 2000 Feb; 214(2):349-57. PubMed ID: 10671580
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Transarterial chemoembolization plus computed tomography-guided percutaneous radiofrequency ablation for small hepatocellular carcinoma in special locations].
    Guo YJ; Huang WS; Zhou B; Chen JW; Cai MY; Qian JS; Huang MS; Shan H; Zhu KS
    Zhonghua Yi Xue Za Zhi; 2013 Sep; 93(33):2627-30. PubMed ID: 24360041
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Advanced Hepatocellular Carcinoma: Pretreatment Contrast-enhanced CT Texture Parameters as Predictive Biomarkers of Survival in Patients Treated with Sorafenib.
    Mulé S; Thiefin G; Costentin C; Durot C; Rahmouni A; Luciani A; Hoeffel C
    Radiology; 2018 Aug; 288(2):445-455. PubMed ID: 29584597
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dynamic Contrast-Enhanced Magnetic Resonance Imaging With Gadolinium Ethoxybenzyl Diethylenetriamine Pentaacetic Acid for Quantitative Assessment of Vascular Effects on Hepatocellular-Carcinoma Lesions Treated by Transarterial Chemoembolization or Radiofrequency Ablation.
    Ippolito D; Trattenero C; Talei Franzesi C; Casiraghi A; Lombardi S; Vacirca F; Corso R; Sironi S
    J Comput Assist Tomogr; 2016; 40(5):692-700. PubMed ID: 27560010
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Postbiopsy arterioportal fistula in patients with hepatocellular carcinoma: clinical significance in transarterial chemoembolization.
    Park HS; Lee SH; Kim YI; Lee JS; Lim MK; Park JW; Lee JH; Kim CM
    AJR Am J Roentgenol; 2006 Feb; 186(2):556-61. PubMed ID: 16423968
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatocellular carcinoma: CT for tumor response after transarterial chemoembolization in patients exceeding Milan criteria--selection parameter for liver transplantation.
    Bargellini I; Vignali C; Cioni R; Petruzzi P; Cicorelli A; Campani D; De Simone P; Filipponi F; Bartolozzi C
    Radiology; 2010 Apr; 255(1):289-300. PubMed ID: 20308465
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Correlation of multislice CT and histomorphology in HCC following TACE: predictors of outcome.
    Herber S; Biesterfeld S; Franz U; Schneider J; Thies J; Schuchmann M; Düber C; Pitton MB; Otto G
    Cardiovasc Intervent Radiol; 2008; 31(4):768-77. PubMed ID: 18196335
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Single center experience over a 5-year period with sequential transarterial chemoembolization (TACE) in the treatment of hepatocellular carcinoma (HCC)].
    Herber SC; Otto G; Woerns M; Moench C; Kanzler S; Junginger T; Schneider J; Schuchmann M; Kummer I; Manzl N; Düber C; Pitton MB
    Rofo; 2007 Mar; 179(3):289-99. PubMed ID: 17325996
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transarterial chemoembolization with cisplatin as second-line treatment for hepatocellular carcinoma unresponsive to chemoembolization with epirubicin-Lipiodol emulsion.
    Maeda N; Osuga K; Higashihara H; Tomoda K; Mikami K; Nakazawa T; Nakamura H; Tomiyama N
    Cardiovasc Intervent Radiol; 2012 Feb; 35(1):82-9. PubMed ID: 21203761
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Parenchymal Blood Volume Assessed by C-Arm-Based Computed Tomography in Immediate Posttreatment Evaluation of Drug-Eluting Bead Transarterial Chemoembolization in Hepatocellular Carcinoma.
    Syha R; Grözinger G; Grosse U; Maurer M; Zender L; Horger M; Nikolaou K; Ketelsen D
    Invest Radiol; 2016 Feb; 51(2):121-6. PubMed ID: 26488373
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dual-energy CT to detect recurrent HCC after TACE: initial experience of color-coded iodine CT imaging.
    Lee JA; Jeong WK; Kim Y; Song SY; Kim J; Heo JN; Park CK
    Eur J Radiol; 2013 Apr; 82(4):569-76. PubMed ID: 23238365
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic Value of 18-Fluorodeoxyglucose-Positron Emission Tomography After Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma Undergoing Orthotopic Liver Transplantation.
    Cascales-Campos PA; Ramírez P; Lopez V; Gonzalez R; Saenz-Mateos L; Llacer E; Sánchez Bueno F; Robles R; Pons JA; Capel A; Frutos L; Navarro JL; Muñoz-Ramon P; Parrilla P
    Transplant Proc; 2015 Oct; 47(8):2374-6. PubMed ID: 26518931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.